Tang Capital Management LLC lessened its stake in shares of Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI – Get Rating ) by 62.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 240,000 shares of the biopharmaceutical company's stock after selling 400,000 shares during the period. Intra-Cellular Therapies accounts for 1.8% of Tang Capital Management LLC's holdings, making the stock its 17th largest position. Tang Capital Management LLC's holdings in Intra-Cellular Therapies were worth $12,701,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

https://www.dailypolitical.com/2023/06/10/tang-capital-management-llc-sells-400000-shares-of-intra-cellular-therapies-inc-nasdaqitci.html

#dailypolitical